Results 41 to 50 of about 6,082,701 (308)

Plasma Urate in REM Sleep Behavior Disorder [PDF]

open access: yes, 2013
Artículo de publicación ISIBackground: Rapid eye movement (REM) sleep behavior disorder (RBD) is associated with a high risk of developing Parkinson’s disease (PD). Higher urate levels are associated with a lower risk of PD.
Uribe San Martín, Reinaldo   +21 more
core   +1 more source

Biomarkers of neurodegeneration in isolated and antidepressant-related REM sleep behavior disorder.

open access: yes, 2023
<p>Dataset relative to the manuscript "Biomarkers of neurodegeneration in isolated and antidepressant-related REM sleep behavior disorder."</p ...
Vandi, Stefano   +8 more
core   +1 more source

A Solution‐Processable Single‐Component Molecular Antiferromagnet

open access: yesAngewandte Chemie, EarlyView.
Au(4OEt), a diethoxybenzene‐fused neutral‐radical gold dithiolene complex, represents a rare solution‐processable single‐component molecular antiferromagnet. Its two‐dimensional herringbone framework and ethoxy groups enable crystalline magnetic thin films.
So Yokomori   +9 more
wiley   +2 more sources

Subtle gait changes in patients with REM Behavior Disorder

open access: yesMovement Disorders, 2013
Many people with rapid eye movement (REM) sleep behavior disorder (RBD) have an underlying synucleinopathy, the most common of which is Lewy body disease.
Eric M. McDade   +11 more
semanticscholar   +1 more source

Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review

open access: yesBrain Sciences, 2021
REM sleep without atonia (RSWA) is the polysomnographic (PSG) hallmark of rapid eye movement (REM) sleep behavior disorder (RBD), a feature essential for the diagnosis of this condition.
Michela Figorilli   +7 more
doaj   +1 more source

Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease

open access: yes, 2023
Michela Figorilli,1 Mario Meloni,2 Giuseppe Lanza,3,4 Elisa Casaglia,1 Rosamaria Lecca,1 Francesca Lea Saibene,2 Patrizia Congiu,1 Monica Puligheddu1 1Sleep Disorder Research Center, Department of Medical Sciences and Public Health, University of ...
Saibene FL   +7 more
core  

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Epigenetic clocks suggest accelerated aging in patients with isolated REM Sleep Behavior Disorder

open access: yesnpj Parkinson's Disease, 2023
Isolated REM Sleep Behavior Disorder (iRBD) is the strongest prodromal marker for α-synucleinopathies. Overt α-synucleinopathies and aging share several mechanisms, but this relationship has been poorly investigated in prodromal phases.
Luca Baldelli   +11 more
doaj   +1 more source

Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives

open access: yesNature Communications, 2023
Microbiota-gut-brain axis may play an important role in Parkinson’s disease (PD). Here, the authors assess gut microbiota in early PD, REM sleep behaviour disorder (RBD) and first-degree relatives of RBD and show PD-like gut dysbiosis occurs in RBD and ...
Bei Huang   +18 more
semanticscholar   +1 more source

Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy